A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session6164309dfe16eca438014d5846027b7aa62c43f1): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global In-Vitro Diagnostic Market Research Report 2024

img

Global In-Vitro Diagnostic Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global In-Vitro Diagnostic Market Research Report 2024

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
According to MRAResearch’s new survey, global In-Vitro Diagnostic market is projected to reach US$ 91350 million in 2033, increasing from US$ 64460 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In-Vitro Diagnostic market research.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 28% of the whole market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In-Vitro Diagnostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
Johnson and Johnson
BD
Danaher
Thermo Fisher Scientific
Bio-Rad
Hologic
KEM-EN-TEC Diagnostics
Medtronic
Omega Diagnostics
Ortho Clinical Diagnostics
Roche
Siemens Healthineers
Sysmex
Atlas Genetics
ELITechGroup
Biomerieux
Werfen
Segment by Type
Test Equipment
Test Reagents

Segment by Application


Hospitals and Clinics
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In-Vitro Diagnostic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Test Equipment
1.2.3 Test Reagents
1.3 Market by Application
1.3.1 Global In-Vitro Diagnostic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Diagnostic Market Perspective (2018-2033)
2.2 In-Vitro Diagnostic Growth Trends by Region
2.2.1 Global In-Vitro Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 In-Vitro Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 In-Vitro Diagnostic Forecasted Market Size by Region (2024-2033)
2.3 In-Vitro Diagnostic Market Dynamics
2.3.1 In-Vitro Diagnostic Industry Trends
2.3.2 In-Vitro Diagnostic Market Drivers
2.3.3 In-Vitro Diagnostic Market Challenges
2.3.4 In-Vitro Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Diagnostic Players by Revenue
3.1.1 Global Top In-Vitro Diagnostic Players by Revenue (2018-2023)
3.1.2 Global In-Vitro Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global In-Vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Diagnostic Revenue
3.4 Global In-Vitro Diagnostic Market Concentration Ratio
3.4.1 Global In-Vitro Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostic Revenue in 2022
3.5 In-Vitro Diagnostic Key Players Head office and Area Served
3.6 Key Players In-Vitro Diagnostic Product Solution and Service
3.7 Date of Enter into In-Vitro Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Diagnostic Breakdown Data by Type
4.1 Global In-Vitro Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global In-Vitro Diagnostic Forecasted Market Size by Type (2024-2033)
5 In-Vitro Diagnostic Breakdown Data by Application
5.1 Global In-Vitro Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global In-Vitro Diagnostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America In-Vitro Diagnostic Market Size (2018-2033)
6.2 North America In-Vitro Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America In-Vitro Diagnostic Market Size by Country (2018-2023)
6.4 North America In-Vitro Diagnostic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Diagnostic Market Size (2018-2033)
7.2 Europe In-Vitro Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe In-Vitro Diagnostic Market Size by Country (2018-2023)
7.4 Europe In-Vitro Diagnostic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Diagnostic Market Size (2018-2033)
8.2 Asia-Pacific In-Vitro Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific In-Vitro Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific In-Vitro Diagnostic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Diagnostic Market Size (2018-2033)
9.2 Latin America In-Vitro Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America In-Vitro Diagnostic Market Size by Country (2018-2023)
9.4 Latin America In-Vitro Diagnostic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Diagnostic Market Size (2018-2033)
10.2 Middle East & Africa In-Vitro Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa In-Vitro Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa In-Vitro Diagnostic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott In-Vitro Diagnostic Introduction
11.1.4 Abbott Revenue in In-Vitro Diagnostic Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Company Detail
11.2.2 Johnson and Johnson Business Overview
11.2.3 Johnson and Johnson In-Vitro Diagnostic Introduction
11.2.4 Johnson and Johnson Revenue in In-Vitro Diagnostic Business (2018-2023)
11.2.5 Johnson and Johnson Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD In-Vitro Diagnostic Introduction
11.3.4 BD Revenue in In-Vitro Diagnostic Business (2018-2023)
11.3.5 BD Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher In-Vitro Diagnostic Introduction
11.4.4 Danaher Revenue in In-Vitro Diagnostic Business (2018-2023)
11.4.5 Danaher Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific In-Vitro Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in In-Vitro Diagnostic Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad In-Vitro Diagnostic Introduction
11.6.4 Bio-Rad Revenue in In-Vitro Diagnostic Business (2018-2023)
11.6.5 Bio-Rad Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic In-Vitro Diagnostic Introduction
11.7.4 Hologic Revenue in In-Vitro Diagnostic Business (2018-2023)
11.7.5 Hologic Recent Development
11.8 KEM-EN-TEC Diagnostics
11.8.1 KEM-EN-TEC Diagnostics Company Detail
11.8.2 KEM-EN-TEC Diagnostics Business Overview
11.8.3 KEM-EN-TEC Diagnostics In-Vitro Diagnostic Introduction
11.8.4 KEM-EN-TEC Diagnostics Revenue in In-Vitro Diagnostic Business (2018-2023)
11.8.5 KEM-EN-TEC Diagnostics Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic In-Vitro Diagnostic Introduction
11.9.4 Medtronic Revenue in In-Vitro Diagnostic Business (2018-2023)
11.9.5 Medtronic Recent Development
11.10 Omega Diagnostics
11.10.1 Omega Diagnostics Company Detail
11.10.2 Omega Diagnostics Business Overview
11.10.3 Omega Diagnostics In-Vitro Diagnostic Introduction
11.10.4 Omega Diagnostics Revenue in In-Vitro Diagnostic Business (2018-2023)
11.10.5 Omega Diagnostics Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics In-Vitro Diagnostic Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostic Business (2018-2023)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Roche
11.12.1 Roche Company Detail
11.12.2 Roche Business Overview
11.12.3 Roche In-Vitro Diagnostic Introduction
11.12.4 Roche Revenue in In-Vitro Diagnostic Business (2018-2023)
11.12.5 Roche Recent Development
11.13 Siemens Healthineers
11.13.1 Siemens Healthineers Company Detail
11.13.2 Siemens Healthineers Business Overview
11.13.3 Siemens Healthineers In-Vitro Diagnostic Introduction
11.13.4 Siemens Healthineers Revenue in In-Vitro Diagnostic Business (2018-2023)
11.13.5 Siemens Healthineers Recent Development
11.14 Sysmex
11.14.1 Sysmex Company Detail
11.14.2 Sysmex Business Overview
11.14.3 Sysmex In-Vitro Diagnostic Introduction
11.14.4 Sysmex Revenue in In-Vitro Diagnostic Business (2018-2023)
11.14.5 Sysmex Recent Development
11.15 Atlas Genetics
11.15.1 Atlas Genetics Company Detail
11.15.2 Atlas Genetics Business Overview
11.15.3 Atlas Genetics In-Vitro Diagnostic Introduction
11.15.4 Atlas Genetics Revenue in In-Vitro Diagnostic Business (2018-2023)
11.15.5 Atlas Genetics Recent Development
11.16 ELITechGroup
11.16.1 ELITechGroup Company Detail
11.16.2 ELITechGroup Business Overview
11.16.3 ELITechGroup In-Vitro Diagnostic Introduction
11.16.4 ELITechGroup Revenue in In-Vitro Diagnostic Business (2018-2023)
11.16.5 ELITechGroup Recent Development
11.17 Biomerieux
11.17.1 Biomerieux Company Detail
11.17.2 Biomerieux Business Overview
11.17.3 Biomerieux In-Vitro Diagnostic Introduction
11.17.4 Biomerieux Revenue in In-Vitro Diagnostic Business (2018-2023)
11.17.5 Biomerieux Recent Development
11.18 Werfen
11.18.1 Werfen Company Detail
11.18.2 Werfen Business Overview
11.18.3 Werfen In-Vitro Diagnostic Introduction
11.18.4 Werfen Revenue in In-Vitro Diagnostic Business (2018-2023)
11.18.5 Werfen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In-Vitro Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Test Equipment
Table 3. Key Players of Test Reagents
Table 4. Global In-Vitro Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global In-Vitro Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global In-Vitro Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global In-Vitro Diagnostic Market Share by Region (2018-2023)
Table 8. Global In-Vitro Diagnostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global In-Vitro Diagnostic Market Share by Region (2024-2033)
Table 10. In-Vitro Diagnostic Market Trends
Table 11. In-Vitro Diagnostic Market Drivers
Table 12. In-Vitro Diagnostic Market Challenges
Table 13. In-Vitro Diagnostic Market Restraints
Table 14. Global In-Vitro Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global In-Vitro Diagnostic Market Share by Players (2018-2023)
Table 16. Global Top In-Vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostic as of 2022)
Table 17. Ranking of Global Top In-Vitro Diagnostic Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by In-Vitro Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In-Vitro Diagnostic Product Solution and Service
Table 21. Date of Enter into In-Vitro Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-Vitro Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global In-Vitro Diagnostic Revenue Market Share by Type (2018-2023)
Table 25. Global In-Vitro Diagnostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global In-Vitro Diagnostic Revenue Market Share by Type (2024-2033)
Table 27. Global In-Vitro Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global In-Vitro Diagnostic Revenue Market Share by Application (2018-2023)
Table 29. Global In-Vitro Diagnostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global In-Vitro Diagnostic Revenue Market Share by Application (2024-2033)
Table 31. North America In-Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America In-Vitro Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America In-Vitro Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe In-Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe In-Vitro Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe In-Vitro Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific In-Vitro Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific In-Vitro Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific In-Vitro Diagnostic Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America In-Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America In-Vitro Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America In-Vitro Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa In-Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa In-Vitro Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa In-Vitro Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott In-Vitro Diagnostic Product
Table 49. Abbott Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Johnson and Johnson Company Detail
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson In-Vitro Diagnostic Product
Table 54. Johnson and Johnson Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 55. Johnson and Johnson Recent Development
Table 56. BD Company Detail
Table 57. BD Business Overview
Table 58. BD In-Vitro Diagnostic Product
Table 59. BD Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 60. BD Recent Development
Table 61. Danaher Company Detail
Table 62. Danaher Business Overview
Table 63. Danaher In-Vitro Diagnostic Product
Table 64. Danaher Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 65. Danaher Recent Development
Table 66. Thermo Fisher Scientific Company Detail
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific In-Vitro Diagnostic Product
Table 69. Thermo Fisher Scientific Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Bio-Rad Company Detail
Table 72. Bio-Rad Business Overview
Table 73. Bio-Rad In-Vitro Diagnostic Product
Table 74. Bio-Rad Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 75. Bio-Rad Recent Development
Table 76. Hologic Company Detail
Table 77. Hologic Business Overview
Table 78. Hologic In-Vitro Diagnostic Product
Table 79. Hologic Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 80. Hologic Recent Development
Table 81. KEM-EN-TEC Diagnostics Company Detail
Table 82. KEM-EN-TEC Diagnostics Business Overview
Table 83. KEM-EN-TEC Diagnostics In-Vitro Diagnostic Product
Table 84. KEM-EN-TEC Diagnostics Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 85. KEM-EN-TEC Diagnostics Recent Development
Table 86. Medtronic Company Detail
Table 87. Medtronic Business Overview
Table 88. Medtronic In-Vitro Diagnostic Product
Table 89. Medtronic Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 90. Medtronic Recent Development
Table 91. Omega Diagnostics Company Detail
Table 92. Omega Diagnostics Business Overview
Table 93. Omega Diagnostics In-Vitro Diagnostic Product
Table 94. Omega Diagnostics Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 95. Omega Diagnostics Recent Development
Table 96. Ortho Clinical Diagnostics Company Detail
Table 97. Ortho Clinical Diagnostics Business Overview
Table 98. Ortho Clinical Diagnostics In-Vitro Diagnostic Product
Table 99. Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 100. Ortho Clinical Diagnostics Recent Development
Table 101. Roche Company Detail
Table 102. Roche Business Overview
Table 103. Roche In-Vitro Diagnostic Product
Table 104. Roche Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 105. Roche Recent Development
Table 106. Siemens Healthineers Company Detail
Table 107. Siemens Healthineers Business Overview
Table 108. Siemens Healthineers In-Vitro Diagnostic Product
Table 109. Siemens Healthineers Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 110. Siemens Healthineers Recent Development
Table 111. Sysmex Company Detail
Table 112. Sysmex Business Overview
Table 113. Sysmex In-Vitro Diagnostic Product
Table 114. Sysmex Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 115. Sysmex Recent Development
Table 116. Atlas Genetics Company Detail
Table 117. Atlas Genetics Business Overview
Table 118. Atlas Genetics In-Vitro Diagnostic Product
Table 119. Atlas Genetics Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 120. Atlas Genetics Recent Development
Table 121. ELITechGroup Company Detail
Table 122. ELITechGroup Business Overview
Table 123. ELITechGroup In-Vitro Diagnostic Product
Table 124. ELITechGroup Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 125. ELITechGroup Recent Development
Table 126. Biomerieux Company Detail
Table 127. Biomerieux Business Overview
Table 128. Biomerieux In-Vitro Diagnostic Product
Table 129. Biomerieux Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 130. Biomerieux Recent Development
Table 131. Werfen Company Detail
Table 132. Werfen Business Overview
Table 133. Werfen In-Vitro Diagnostic Product
Table 134. Werfen Revenue in In-Vitro Diagnostic Business (2018-2023) & (US$ Million)
Table 135. Werfen Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Diagnostic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global In-Vitro Diagnostic Market Share by Type: 2022 VS 2033
Figure 3. Test Equipment Features
Figure 4. Test Reagents Features
Figure 5. Global In-Vitro Diagnostic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global In-Vitro Diagnostic Market Share by Application: 2022 VS 2033
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Diagnostic Center Case Studies
Figure 9. In-Vitro Diagnostic Report Years Considered
Figure 10. Global In-Vitro Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global In-Vitro Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global In-Vitro Diagnostic Market Share by Region: 2022 VS 2033
Figure 13. Global In-Vitro Diagnostic Market Share by Players in 2022
Figure 14. Global Top In-Vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostic as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by In-Vitro Diagnostic Revenue in 2022
Figure 16. North America In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America In-Vitro Diagnostic Market Share by Country (2018-2033)
Figure 18. United States In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe In-Vitro Diagnostic Market Share by Country (2018-2033)
Figure 22. Germany In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific In-Vitro Diagnostic Market Share by Region (2018-2033)
Figure 30. China In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America In-Vitro Diagnostic Market Share by Country (2018-2033)
Figure 38. Mexico In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa In-Vitro Diagnostic Market Share by Country (2018-2033)
Figure 42. Turkey In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia In-Vitro Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Abbott Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 45. Johnson and Johnson Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 46. BD Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 47. Danaher Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 49. Bio-Rad Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 50. Hologic Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 51. KEM-EN-TEC Diagnostics Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 52. Medtronic Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 53. Omega Diagnostics Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 54. Ortho Clinical Diagnostics Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 55. Roche Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 56. Siemens Healthineers Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 57. Sysmex Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 58. Atlas Genetics Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 59. ELITechGroup Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 60. Biomerieux Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 61. Werfen Revenue Growth Rate in In-Vitro Diagnostic Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed